Featured

October 7, 2019

Carisma Presents at the Chardan 3rd Annual Genetic Medicines Conference

Carisma Therapeutics will present at the Chardan 3rd Annual Genetic Medicines Conference being held October 7-8, 2019, at the Westin New York Grand Central in New York City. Steven Kelly, President and Chief Executive Officer will be presenting at 11:30 Eastern Time on Tuesday, October 8.

Read More

News

September 9, 2019

Carisma Enters into a Research Collaboration with Phio Pharmaceuticals

“Metastatic solid tumors have been an intractable challenge for engineered cell therapies. Our platform technology, based on the genetically engineered macrophage, has a unique opportunity to provide benefit in this disease state,” said Dr. Michael Klichinsky, co-Founder and Vice President of Discovery at Carisma. “We are excited to work with Phio to evaluate sd-rxRNA mediated […]

Read More
June 3, 2019

Carisma Therapeutics Names Dr. Robert Petit as Chief Scientific Officer

Carisma Therapeutics is excited to welcome Robert Petit, PhD as its Chief Scientific Officer. Dr. Petit is an accomplished immuno-oncology scientist, innovator and drug developer, and a C-level executive with 25 years of experience in building and leading scientific, translational, and clinical development teams in public and private companies. View press release here.

Read More
May 9, 2019

Michael Klichinsky, VP of Discovery Research, Presents at the CAR-T and the Rise of Cellicon Valley Conference

Carisma’s Michael Klichinsky, VP of Discovery Research, joins leaders in cell therapy to present at the CAR-T and the Rise of Cellicon Valley conference to be held May 9-10, 2019 at the University of Pennsylvania (Penn). The forum is presented by Penn’s Abramson Cancer Center, the Children’s Hospital of Philadelphia and Penn’s Center for Cellular […]

Read More